Cramer says Regeneron stock is the best bet among health-care companies fighting Covid

Jim Cramer
Scott Mlyn | CNBC

The stock of health-care company Regeneron could rise as its antibody treatment sees wider use in the fight against Covid-19, CNBC's Jim Cramer said Monday.

More In CNBC TV Picks

CNBC ProMohamed El-Erian says Fed should keep focus on inflation even with economy 'weakening really fast'
CNBC ProDan Niles dumps internet stocks ahead of an 'ugly' week of earnings
CNBC ProMarket bottom is coming later this year, Interactive Brokers' Peterffy says